0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PROTAC Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15H16861
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PROTAC Drug Market Research Report 2024
BUY CHAPTERS

Global PROTAC Drug Market Research Report 2025

Code: QYRE-Auto-15H16861
Report
September 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PROTAC Drug Market

The global market for PROTAC Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for PROTAC Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for PROTAC Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for PROTAC Drug in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of PROTAC Drug include Arvinas, Nurix, Kymera Therapeutics, C4 Therapeutics, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PROTAC Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PROTAC Drug.
The PROTAC Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PROTAC Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PROTAC Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of PROTAC Drug Market Report

Report Metric Details
Report Name PROTAC Drug Market
Segment by Type
  • Based on CRBN
  • Based on VHL
Segment by Application
  • Cancer
  • Autoimmune Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Arvinas, Nurix, Kymera Therapeutics, C4 Therapeutics, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of PROTAC Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PROTAC Drug Market report?

Ans: The main players in the PROTAC Drug Market are Arvinas, Nurix, Kymera Therapeutics, C4 Therapeutics, Ranok Therapeutics, Accutar Biotechnology, BeiGene Ltd., Hinova Pharmaceuticals, Haisco Pharmaceutical

What are the Application segmentation covered in the PROTAC Drug Market report?

Ans: The Applications covered in the PROTAC Drug Market report are Cancer, Autoimmune Diseases, Other

What are the Type segmentation covered in the PROTAC Drug Market report?

Ans: The Types covered in the PROTAC Drug Market report are Based on CRBN, Based on VHL

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PROTAC Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Based on CRBN
1.2.3 Based on VHL
1.3 Market by Application
1.3.1 Global PROTAC Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PROTAC Drug Market Perspective (2020-2031)
2.2 Global PROTAC Drug Growth Trends by Region
2.2.1 Global PROTAC Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 PROTAC Drug Historic Market Size by Region (2020-2025)
2.2.3 PROTAC Drug Forecasted Market Size by Region (2026-2031)
2.3 PROTAC Drug Market Dynamics
2.3.1 PROTAC Drug Industry Trends
2.3.2 PROTAC Drug Market Drivers
2.3.3 PROTAC Drug Market Challenges
2.3.4 PROTAC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PROTAC Drug Players by Revenue
3.1.1 Global Top PROTAC Drug Players by Revenue (2020-2025)
3.1.2 Global PROTAC Drug Revenue Market Share by Players (2020-2025)
3.2 Global PROTAC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by PROTAC Drug Revenue
3.4 Global PROTAC Drug Market Concentration Ratio
3.4.1 Global PROTAC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PROTAC Drug Revenue in 2024
3.5 Global Key Players of PROTAC Drug Head office and Area Served
3.6 Global Key Players of PROTAC Drug, Product and Application
3.7 Global Key Players of PROTAC Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PROTAC Drug Breakdown Data by Type
4.1 Global PROTAC Drug Historic Market Size by Type (2020-2025)
4.2 Global PROTAC Drug Forecasted Market Size by Type (2026-2031)
5 PROTAC Drug Breakdown Data by Application
5.1 Global PROTAC Drug Historic Market Size by Application (2020-2025)
5.2 Global PROTAC Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America PROTAC Drug Market Size (2020-2031)
6.2 North America PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America PROTAC Drug Market Size by Country (2020-2025)
6.4 North America PROTAC Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PROTAC Drug Market Size (2020-2031)
7.2 Europe PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe PROTAC Drug Market Size by Country (2020-2025)
7.4 Europe PROTAC Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PROTAC Drug Market Size (2020-2031)
8.2 Asia-Pacific PROTAC Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific PROTAC Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific PROTAC Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PROTAC Drug Market Size (2020-2031)
9.2 Latin America PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America PROTAC Drug Market Size by Country (2020-2025)
9.4 Latin America PROTAC Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PROTAC Drug Market Size (2020-2031)
10.2 Middle East & Africa PROTAC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa PROTAC Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa PROTAC Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas PROTAC Drug Introduction
11.1.4 Arvinas Revenue in PROTAC Drug Business (2020-2025)
11.1.5 Arvinas Recent Development
11.2 Nurix
11.2.1 Nurix Company Details
11.2.2 Nurix Business Overview
11.2.3 Nurix PROTAC Drug Introduction
11.2.4 Nurix Revenue in PROTAC Drug Business (2020-2025)
11.2.5 Nurix Recent Development
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Details
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics PROTAC Drug Introduction
11.3.4 Kymera Therapeutics Revenue in PROTAC Drug Business (2020-2025)
11.3.5 Kymera Therapeutics Recent Development
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Details
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics PROTAC Drug Introduction
11.4.4 C4 Therapeutics Revenue in PROTAC Drug Business (2020-2025)
11.4.5 C4 Therapeutics Recent Development
11.5 Ranok Therapeutics
11.5.1 Ranok Therapeutics Company Details
11.5.2 Ranok Therapeutics Business Overview
11.5.3 Ranok Therapeutics PROTAC Drug Introduction
11.5.4 Ranok Therapeutics Revenue in PROTAC Drug Business (2020-2025)
11.5.5 Ranok Therapeutics Recent Development
11.6 Accutar Biotechnology
11.6.1 Accutar Biotechnology Company Details
11.6.2 Accutar Biotechnology Business Overview
11.6.3 Accutar Biotechnology PROTAC Drug Introduction
11.6.4 Accutar Biotechnology Revenue in PROTAC Drug Business (2020-2025)
11.6.5 Accutar Biotechnology Recent Development
11.7 BeiGene Ltd.
11.7.1 BeiGene Ltd. Company Details
11.7.2 BeiGene Ltd. Business Overview
11.7.3 BeiGene Ltd. PROTAC Drug Introduction
11.7.4 BeiGene Ltd. Revenue in PROTAC Drug Business (2020-2025)
11.7.5 BeiGene Ltd. Recent Development
11.8 Hinova Pharmaceuticals
11.8.1 Hinova Pharmaceuticals Company Details
11.8.2 Hinova Pharmaceuticals Business Overview
11.8.3 Hinova Pharmaceuticals PROTAC Drug Introduction
11.8.4 Hinova Pharmaceuticals Revenue in PROTAC Drug Business (2020-2025)
11.8.5 Hinova Pharmaceuticals Recent Development
11.9 Haisco Pharmaceutical
11.9.1 Haisco Pharmaceutical Company Details
11.9.2 Haisco Pharmaceutical Business Overview
11.9.3 Haisco Pharmaceutical PROTAC Drug Introduction
11.9.4 Haisco Pharmaceutical Revenue in PROTAC Drug Business (2020-2025)
11.9.5 Haisco Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global PROTAC Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Based on CRBN
 Table 3. Key Players of Based on VHL
 Table 4. Global PROTAC Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global PROTAC Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global PROTAC Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global PROTAC Drug Market Share by Region (2020-2025)
 Table 8. Global PROTAC Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global PROTAC Drug Market Share by Region (2026-2031)
 Table 10. PROTAC Drug Market Trends
 Table 11. PROTAC Drug Market Drivers
 Table 12. PROTAC Drug Market Challenges
 Table 13. PROTAC Drug Market Restraints
 Table 14. Global PROTAC Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global PROTAC Drug Market Share by Players (2020-2025)
 Table 16. Global Top PROTAC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PROTAC Drug as of 2024)
 Table 17. Ranking of Global Top PROTAC Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by PROTAC Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of PROTAC Drug, Headquarters and Area Served
 Table 20. Global Key Players of PROTAC Drug, Product and Application
 Table 21. Global Key Players of PROTAC Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global PROTAC Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global PROTAC Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global PROTAC Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global PROTAC Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global PROTAC Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global PROTAC Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global PROTAC Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global PROTAC Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific PROTAC Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific PROTAC Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific PROTAC Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa PROTAC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa PROTAC Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa PROTAC Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Arvinas Company Details
 Table 47. Arvinas Business Overview
 Table 48. Arvinas PROTAC Drug Product
 Table 49. Arvinas Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 50. Arvinas Recent Development
 Table 51. Nurix Company Details
 Table 52. Nurix Business Overview
 Table 53. Nurix PROTAC Drug Product
 Table 54. Nurix Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 55. Nurix Recent Development
 Table 56. Kymera Therapeutics Company Details
 Table 57. Kymera Therapeutics Business Overview
 Table 58. Kymera Therapeutics PROTAC Drug Product
 Table 59. Kymera Therapeutics Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 60. Kymera Therapeutics Recent Development
 Table 61. C4 Therapeutics Company Details
 Table 62. C4 Therapeutics Business Overview
 Table 63. C4 Therapeutics PROTAC Drug Product
 Table 64. C4 Therapeutics Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 65. C4 Therapeutics Recent Development
 Table 66. Ranok Therapeutics Company Details
 Table 67. Ranok Therapeutics Business Overview
 Table 68. Ranok Therapeutics PROTAC Drug Product
 Table 69. Ranok Therapeutics Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 70. Ranok Therapeutics Recent Development
 Table 71. Accutar Biotechnology Company Details
 Table 72. Accutar Biotechnology Business Overview
 Table 73. Accutar Biotechnology PROTAC Drug Product
 Table 74. Accutar Biotechnology Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 75. Accutar Biotechnology Recent Development
 Table 76. BeiGene Ltd. Company Details
 Table 77. BeiGene Ltd. Business Overview
 Table 78. BeiGene Ltd. PROTAC Drug Product
 Table 79. BeiGene Ltd. Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 80. BeiGene Ltd. Recent Development
 Table 81. Hinova Pharmaceuticals Company Details
 Table 82. Hinova Pharmaceuticals Business Overview
 Table 83. Hinova Pharmaceuticals PROTAC Drug Product
 Table 84. Hinova Pharmaceuticals Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 85. Hinova Pharmaceuticals Recent Development
 Table 86. Haisco Pharmaceutical Company Details
 Table 87. Haisco Pharmaceutical Business Overview
 Table 88. Haisco Pharmaceutical PROTAC Drug Product
 Table 89. Haisco Pharmaceutical Revenue in PROTAC Drug Business (2020-2025) & (US$ Million)
 Table 90. Haisco Pharmaceutical Recent Development
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources
 Table 94. Authors List of This Report


List of Figures
 Figure 1. PROTAC Drug Picture
 Figure 2. Global PROTAC Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PROTAC Drug Market Share by Type: 2024 VS 2031
 Figure 4. Based on CRBN Features
 Figure 5. Based on VHL Features
 Figure 6. Global PROTAC Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global PROTAC Drug Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Autoimmune Diseases Case Studies
 Figure 10. Other Case Studies
 Figure 11. PROTAC Drug Report Years Considered
 Figure 12. Global PROTAC Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global PROTAC Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global PROTAC Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global PROTAC Drug Market Share by Players in 2024
 Figure 16. Global Top PROTAC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PROTAC Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by PROTAC Drug Revenue in 2024
 Figure 18. North America PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America PROTAC Drug Market Share by Country (2020-2031)
 Figure 20. United States PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe PROTAC Drug Market Share by Country (2020-2031)
 Figure 24. Germany PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific PROTAC Drug Market Share by Region (2020-2031)
 Figure 32. China PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America PROTAC Drug Market Share by Country (2020-2031)
 Figure 40. Mexico PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa PROTAC Drug Market Share by Country (2020-2031)
 Figure 44. Turkey PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE PROTAC Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Arvinas Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 48. Nurix Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 49. Kymera Therapeutics Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 50. C4 Therapeutics Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 51. Ranok Therapeutics Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 52. Accutar Biotechnology Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 53. BeiGene Ltd. Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 54. Hinova Pharmaceuticals Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 55. Haisco Pharmaceutical Revenue Growth Rate in PROTAC Drug Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart